logo
#

Latest news with #SILICON2

Asian Market Value Stocks: 3 Companies Estimated Below Intrinsic Worth
Asian Market Value Stocks: 3 Companies Estimated Below Intrinsic Worth

Yahoo

time6 days ago

  • Business
  • Yahoo

Asian Market Value Stocks: 3 Companies Estimated Below Intrinsic Worth

As global markets navigate a complex landscape of economic indicators and policy shifts, the Asian market has shown resilience, with indices in China and Japan posting gains amid strong corporate earnings and robust trade data. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities potentially mispriced by the market; these stocks may offer intrinsic value that is not yet reflected in their current trading prices. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) SRE Holdings (TSE:2980) ¥3180.00 ¥6212.44 48.8% SILICON2 (KOSDAQ:A257720) ₩53700.00 ₩105825.30 49.3% Nanya Technology (TWSE:2408) NT$43.95 NT$87.08 49.5% Jiangsu Yunyi ElectricLtd (SZSE:300304) CN¥11.08 CN¥22.02 49.7% Heartland Group Holdings (NZSE:HGH) NZ$0.80 NZ$1.58 49.5% Guangdong Marubi Biotechnology (SHSE:603983) CN¥40.73 CN¥79.39 48.7% GEM (SZSE:002340) CN¥6.54 CN¥13.00 49.7% Finger (KOSDAQ:A163730) ₩13480.00 ₩26287.68 48.7% cottaLTD (TSE:3359) ¥442.00 ¥867.58 49.1% Andes Technology (TWSE:6533) NT$276.50 NT$541.44 48.9% Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. SILICON2 Overview: SILICON2 Co., Ltd. is involved in the global distribution of cosmetics products and has a market cap of approximately ₩3.52 trillion. Operations: The company generates revenue from its wholesale miscellaneous segment, amounting to ₩787.27 million. Estimated Discount To Fair Value: 49.3% SILICON2 is trading at ₩53,700, significantly below its estimated fair value of ₩105,825.3, presenting a potential undervaluation based on cash flows. Despite recent earnings volatility and high non-cash earnings, its revenue is expected to grow 20.6% annually—outpacing the Korean market's 7.2% growth rate—while profits are forecasted to increase by 20.75% per year. The company's strong first-quarter net income of KRW 38,785 million supports this outlook despite share price volatility. Our comprehensive growth report raises the possibility that SILICON2 is poised for substantial financial growth. Navigate through the intricacies of SILICON2 with our comprehensive financial health report here. Damai Entertainment Holdings Overview: Damai Entertainment Holdings Limited is an investment holding company engaged in content, technology, and IP merchandising and commercialization businesses in Hong Kong and the People's Republic of China, with a market cap of approximately HK$35.25 billion. Operations: The company's revenue segments include CN¥2.06 billion from Damai, CN¥499.92 million from Drama Series Production, CN¥1.43 billion from IP Merchandising and Innovation Initiatives, and CN¥2.71 billion from its Film Technology and Investment, Production, Promotion and Distribution Platform. Estimated Discount To Fair Value: 20.9% Damai Entertainment Holdings, trading at HK$1.18, is undervalued with a fair value estimate of HK$1.49, based on cash flow analysis. Despite recent insider selling and share price volatility, the company reported CNY 6.70 billion in sales for the year ending March 2025—up from CNY 5.03 billion—and net income increased to CNY 363.58 million. Earnings are expected to grow significantly at over 40% annually, outpacing Hong Kong market forecasts. Our earnings growth report unveils the potential for significant increases in Damai Entertainment Holdings' future results. Get an in-depth perspective on Damai Entertainment Holdings' balance sheet by reading our health report here. Accton Technology Overview: Accton Technology Corporation engages in the research, development, manufacturing, and sale of network communication equipment across Taiwan, America, Asia, Europe, and internationally with a market cap of NT$552.76 billion. Operations: Accton Technology Corporation generates revenue through its research, development, manufacturing, and sales activities in the field of network communication equipment across various regions including Taiwan, America, Asia, Europe, and other international markets. Estimated Discount To Fair Value: 37.5% Accton Technology, trading at NT$989, is undervalued with a fair value estimate of NT$1,581.54 based on cash flow analysis. Recent earnings showed significant growth with second-quarter revenue reaching TWD 60.60 billion and net income at TWD 5.03 billion. Despite high share price volatility, the company's earnings grew by 83.2% over the past year and are forecast to grow significantly at 22.8% annually, outpacing Taiwan's market expectations. The analysis detailed in our Accton Technology growth report hints at robust future financial performance. Take a closer look at Accton Technology's balance sheet health here in our report. Key Takeaways Click through to start exploring the rest of the 274 Undervalued Asian Stocks Based On Cash Flows now. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A257720 SEHK:1060 and TWSE:2345. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

3 Asian Stocks Estimated To Be Up To 35.3% Below Intrinsic Value
3 Asian Stocks Estimated To Be Up To 35.3% Below Intrinsic Value

Yahoo

time17-07-2025

  • Business
  • Yahoo

3 Asian Stocks Estimated To Be Up To 35.3% Below Intrinsic Value

Amidst the backdrop of global trade tensions and muted market reactions to new tariffs, Asian markets have experienced a mix of challenges and opportunities. With investor sentiment influenced by economic data releases and policy shifts, identifying undervalued stocks has become increasingly important for those seeking potential value in the region. In this environment, a good stock is often characterized by strong fundamentals that suggest it may be trading below its intrinsic value, offering potential for future appreciation despite current market uncertainties. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) SILICON2 (KOSDAQ:A257720) ₩52800.00 ₩104187.44 49.3% Range Intelligent Computing Technology Group (SZSE:300442) CN¥52.55 CN¥103.62 49.3% Peijia Medical (SEHK:9996) HK$7.93 HK$15.57 49.1% Nanya New Material TechnologyLtd (SHSE:688519) CN¥42.94 CN¥85.38 49.7% Medy-Tox (KOSDAQ:A086900) ₩162200.00 ₩322233.66 49.7% Mandom (TSE:4917) ¥1419.00 ¥2835.57 50% Livero (TSE:9245) ¥1727.00 ¥3430.34 49.7% Hugel (KOSDAQ:A145020) ₩355000.00 ₩698441.84 49.2% HL Holdings (KOSE:A060980) ₩41500.00 ₩82181.95 49.5% ALUX (KOSDAQ:A475580) ₩11500.00 ₩22593.59 49.1% Click here to see the full list of 253 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. HMT (Xiamen) New Technical Materials Overview: HMT (Xiamen) New Technical Materials Co., Ltd. operates in the technical materials sector and has a market cap of CN¥13.15 billion. Operations: The company's revenue from the automobile parts manufacturing industry is CN¥2.28 billion. Estimated Discount To Fair Value: 35.3% HMT (Xiamen) New Technical Materials is trading at CNY 44.39, significantly below its estimated fair value of CNY 68.64, suggesting it may be undervalued based on cash flows. Despite a recent dividend decrease and ongoing private placement approvals, the company has shown robust revenue growth, with earnings rising by 16% last year and forecasted to grow over 20% annually. However, its return on equity is expected to remain low at around 10.9%. The growth report we've compiled suggests that HMT (Xiamen) New Technical Materials' future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of HMT (Xiamen) New Technical Materials. Eastroc Beverage(Group) Overview: Eastroc Beverage(Group) Co., Ltd. focuses on the research, development, production, and sales of beverages in China with a market cap of CN¥155.49 billion. Operations: The company generates revenue primarily through its production, sales, and wholesale of beverages and pre-packaged foods, totaling CN¥17.20 billion. Estimated Discount To Fair Value: 26.3% Eastroc Beverage (Group) is trading at CN¥299.01, well below its estimated fair value of CN¥405.88, highlighting potential undervaluation based on cash flows. The company has experienced significant earnings growth of 65.1% over the past year and is forecasted to continue growing at 22.99% annually, outpacing the market's revenue growth expectations. However, it faces challenges with an unstable dividend track record and recent removal from a major index constituent list in June 2025. Insights from our recent growth report point to a promising forecast for Eastroc Beverage(Group)'s business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Eastroc Beverage(Group). King Slide Works Overview: King Slide Works Co., Ltd. designs, manufactures, and sells rail kits for computer and network communications equipment, furniture wooden kitchen accessories, slides, and molds across Taiwan, the United States, China, and internationally with a market cap of NT$213.47 billion. Operations: The company's revenue segments include NT$2.12 billion from King Slide Works Co., Ltd. and NT$10.47 billion from King Slide Technology Co., Ltd. Estimated Discount To Fair Value: 13.3% King Slide Works is trading at NT$2,240, slightly below its estimated fair value of NT$2,582.78. The company reported substantial earnings growth over the past year, with net income rising to TWD 2.51 billion in Q1 2025 from TWD 1.39 billion a year prior. Earnings are projected to grow at 14.12% annually, surpassing the TW market's average growth rate and highlighting its potential as an undervalued stock based on cash flows in Asia. Our earnings growth report unveils the potential for significant increases in King Slide Works' future results. Get an in-depth perspective on King Slide Works' balance sheet by reading our health report here. Seize The Opportunity Click this link to deep-dive into the 253 companies within our Undervalued Asian Stocks Based On Cash Flows screener. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Contemplating Other Strategies? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:603306 SHSE:605499 and TWSE:2059. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Global Market's Top 3 Stocks That Could Be Undervalued In June 2025
Global Market's Top 3 Stocks That Could Be Undervalued In June 2025

Yahoo

time11-06-2025

  • Business
  • Yahoo

Global Market's Top 3 Stocks That Could Be Undervalued In June 2025

As global markets navigate a mixed economic landscape, with U.S. stocks climbing for the second consecutive week and European indices buoyed by easing monetary policies, investors are keenly observing the potential impacts of trade tensions and labor market shifts. Amid these developments, identifying undervalued stocks can be particularly appealing as they may offer opportunities for growth when market conditions are uncertain. Name Current Price Fair Value (Est) Discount (Est) Wanguo Gold Group (SEHK:3939) HK$30.70 HK$61.36 50% Sparebank 68° Nord (OB:SB68) NOK179.38 NOK357.46 49.8% Sahara International Petrochemical (SASE:2310) SAR18.98 SAR37.71 49.7% PixArt Imaging (TPEX:3227) NT$220.00 NT$436.00 49.5% Montana Aerospace (SWX:AERO) CHF19.50 CHF38.68 49.6% Good Will Instrument (TWSE:2423) NT$44.30 NT$87.18 49.2% Exsitec Holding (OM:EXS) SEK128.50 SEK254.56 49.5% doValue (BIT:DOV) €2.258 €4.45 49.3% Airbus (ENXTPA:AIR) €163.92 €325.62 49.7% ABO Energy GmbH KGaA (XTRA:AB9) €36.70 €72.88 49.6% Click here to see the full list of 495 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Overview: SILICON2 Co., Ltd. is involved in the global distribution of cosmetics products and has a market cap of ₩3.40 billion. Operations: The company generates revenue primarily through its wholesale miscellaneous segment, which amounts to ₩787.27 million. Estimated Discount To Fair Value: 41.1% SILICON2 is trading at ₩61,800, significantly below its estimated fair value of ₩104,926.19, suggesting it may be undervalued based on cash flows. Despite high volatility in recent months, the company reported strong earnings growth of 134.2% over the past year and forecasts revenue and earnings growth above 20% annually. Recent results showed net income rising to KRW 38,785 million from KRW 25,535.55 million a year ago with improved earnings per share figures. The analysis detailed in our SILICON2 growth report hints at robust future financial performance. Click here and access our complete balance sheet health report to understand the dynamics of SILICON2. Overview: Qingdao Baheal Medical INC. is involved in the research, development, production, and sale of pharmaceutical products with a market cap of approximately CN¥11.10 billion. Operations: The company's revenue is derived from its activities in research, development, production, and sale of pharmaceutical products. Estimated Discount To Fair Value: 15.2% Qingdao Baheal Medical is trading at CNY 23.29, below its estimated fair value of CNY 27.46, indicating potential undervaluation based on cash flows. Despite a slight decline in recent sales and net income compared to the previous year, earnings are projected to grow significantly over the next three years. The company recently affirmed a dividend distribution plan for 2024, reflecting stable shareholder returns amidst moderate revenue growth expectations above the Chinese market average. Our growth report here indicates Qingdao Baheal Medical may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Qingdao Baheal Medical's balance sheet health report. Overview: Fositek Corp. operates in the manufacture and wholesale of electronic materials and components, with a market cap of NT$47.58 billion. Operations: The company's revenue primarily comes from its Electronic Components & Parts segment, generating NT$8.73 billion. Estimated Discount To Fair Value: 47% Fositek is trading at NT$762, significantly below its estimated fair value of NT$1,437.14, highlighting potential undervaluation based on cash flows. The company reported strong first-quarter earnings with net income rising to TWD 356.5 million from TWD 223.95 million year-over-year. Earnings are projected to grow substantially at 33.9% annually over the next three years, outpacing Taiwan's market average growth rates despite recent share price volatility and changes in company bylaws. The growth report we've compiled suggests that Fositek's future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of Fositek. Investigate our full lineup of 495 Undervalued Global Stocks Based On Cash Flows right here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A257720 SZSE:301015 and TWSE:6805. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store